Internist
Amsterdam University Medical Centers
Amsterdam, Netherlands
Michiel Coppens, MD PhD
Amsterdam UMC, Amsterdam, The Netherlands
Dr Michiel Coppens, 46 years old, was trained in internal and vascular medicine at the University of Amsterdam in the Netherlands and continued as medical specialist in mainly Thrombosis & Haemostasis for over 10 years within Amsterdam UMC. He is the Acting Head of the EUHANET and ERN EuroBloodNet certified Haemophilia Comprehensive Care Centre. His current focus of research includes gene therapy for patients with haemophilia A or B. In 2015, he dosed the first Dutch haemophilia patient with gene therapy and has since then dosed a total of 9 patients across different trials. He is a member of the EAHAD working group on Gene Therapy. He is an author on over 150 publications and has a Hirsch index of 31 (Scopus.com).